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Phosphorylation induced by carp-dependent protein kinase was examined in a plasma membrane-en- 
riched fraction from control and P-adrenergic-stimulated rat aortic myocytes. Phosphorylation of a 16 kDa 
protein which copurified with the plasma membrane marker (Nab + Kc)-ATPase was most prominent. It 
was decreased by pretreatment of the myocytes with isoproterenol and the effect of isoproterenol was inhib- 
ited by propranolol. Both phosphorylation induced by CAMP-dependent protein kinase and its inhibition 
by isoproterenoi pretreatment declined in preparations exposed to endogenous phosphatase. These results 
provide strong evidence that @-adrenergic stimuiation of aortic myocytes induces in situ phosphorylation 
of a 16 kDa plasma membrane protein. 
(Rat aorta) 
1. INTRODUCTION 
CAMP has been implicated in smooth muscle 
relaxation induced by ,&adrenergic agonists and 
other drugs [1,2]. It may also be involved in the 
regulation of other cell functions, such as cell divi- 
sion [3,4]. Target proteins for CAMP-dependent 
protein kinase have been studied in various tissues, 
especially cardiac muscle, but are not well-known 
in smooth muscle. CAMP-dependent phosphoryla- 
tion of different substrate proteins has been 
reported in the cytosolic fraction of aortic smaoth 
muscle [5,6]. One such substrate, myosin light 
chain kinase, may be implicated in smooth muscle 
relaxation [6,7]. It has been suggested that CAMP- 
dependent phosphorylation of plasma membrane 
[8,9] or endoplasmic reticulum [IO] proteins could 
regulate membrane Ca2+ transport. However, the 
~~~~e~~a~~~~~~ Iso, (-)-isoproterenol; Pro, dl- 
propranolol; PKA, CAMP-dependent protein kinase; 
PMSF, phenylmethylsulfonyl fluoride 
identification of such substrate proteins is still 
equivocal [6,10-141 and their subcellular localisa- 
tion has not been clearly demonstrated. 
To investigate the existence of membrane 
associated substrates for CAMP-dependent protein 
kinase in vascular smooth muscIe cells, we have 
used membrane fractions derived from rat aortic 
myoc~es in suspension or in culture. These mem- 
brane fractions appear to be less disrupted tlian 
comparable ones derived from whole tissues [15], 
and are not contaminated by membranes from 
non-smooth muscle cells. 
2. MATERIALS AND METHODS 
The aortic media was obtained from IO-week- 
old female Wistar rats after collagenase digestion 
[ 16,171. Suspensions of aortic myocytes [ 181 were 
used directly to obtain membrane fractions or were 
cultured for 8 days in plastic petri dishes. Mem- 
brane fractions were then prepared from confluent 
cultures [16,17]. Microsomal fractions were ob- 
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tained from aortic media and from myocytes in 
suspension or in culture as described by Katten- 
burg and Stoclet [ 151. Plasma membrane-enriched 
fractions were obtained from the corresponding 
microsomal fractions by centrifugation on a 
discontinuous sucrose gradient [ 151. (Na+ + K+)- 
ATPase and NADPH-cytochrome c reductase ac- 
tivities were used as enzyme markers for plasma 
membrane and endoplasmic reticulum, respective- 
ly [ 151. These enzyme activities were measured ac- 
cording to Wuytack et al. [19] and Sottocasa et al. 
[20], respectively. The 2 lightest fractions Fl and 
F2 were enriched in plasma membrane marker ac- 
tivities and were free of mitochondrial contamina- 
tion, but contained some endoplasmic reticulum. 
They were combined and used as the plasma 
membrane-enriched fraction. All protein assays 
were conducted according to Lowry et al. [21], 
with bovine serum albumin as standard. 
Phosphorylation experiments were carried out in 
a total volume of 100~1 at 3O”C, containing: 
100 mM Tris-HCl, 10 mM MgC12, 1 mM EGTA 
(pH 7.0) and 15-2Opg membrane proteins, 
0.2 mM [y-32P]ATP (Mg’+ salt) (2-5 &i/assay) 
and 1 mM CAMP. Reactions were initiated by ad- 
dition of the CAMP-dependent protein kinase 
purified according to Gilman [22,23] and stopped 
by adding 50 ~1 Laemmli solution [24] (182 mM 
Tris-HCl, pH 6.8, 7.5% SDS, 3.6% glycerol, 3.1% 
mercaptoethanol and 0.005% bromophenol blue) 
at 4°C. Boiling of the samples (5 min at 95°C) in 
the presence of 2.5% of SDS did not affect 
phosphate labelling. 
To study the influence of @-adrenergic stimula- 
tion of aortic myocytes in culture on phosphoryla- 
tion of a 16 kDa protein, confluent cells were in- 
cubated at 37°C under 5% CO2/95% O2 for 
various time in 3 ml physiological solution (com- 
position in mM: 122 NaCl, 4.7 KCl, 1.3 CaCl2, 1.2 
MgCL, 15.6 NaHCO3, 11.5 glucose, 1 ascorbic 
acid). Iso (10e7 M) and Pro (5 x 10m7 M) were 
added as indicated. Unless otherwise indicated, 
membranes were prepared in the presence of 
25 mM NaF, a phosphatase inhibitor. Cells were 
then homogenized and plasma membrane-enriched 
fractions were obtained as described [15]. Mem- 
brane fractions were phosphorylated by exogenous 
kinase, CAMP and labelled ATP as above, in the 
presence of 25 mM NaF and then submitted to 
electrophoresis. Phosphorylated samples were 
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loaded on SDS-polyacrylamide slab gels consisting 
of a 5% stacking gel and a 12% separating el ac- 
cording to Laemmli [24]. Phosphate incorporation 
was quantitated by cutting the radioactive band 
from the dried gels and subjecting it to liquid scin- 
tillation counting in 10 ml Aquassure. 
Iso, Pro, Mg’+-ATP and CAMP were purchased 
from Sigma. [y-32P]ATP and Aquassure were ob- 
tained from NEN, France. All other chemicals 
used were of reagent grade. 
3. RESULTS 
Phosphorylation of proteins of the plasma 
membrane-enriched fraction Fl-2 isolated from 
cultured myocytes is illustrated in fig. 1. A number 
of proteins were phosphorylated in the presence of 
labelled ATP and in the absence of exogenous pro- 
tein kinase and CAMP (lane A). Among these was 
a protein of apparent 55 kDa which comigrates 
with the regulatory subunit of the exogenous type 
II CAMP-dependent protein kinase (lane E). Addi- 
membrane A B C 0 E 
-L. 
F,-2 + + + + - 
EAN1P + + + + 
PKA _ _ + - + 
PKL\ hoi&d - - - + - 
Fig. 1. Representative autoradiogram of phosphorylated 
proteins of a plasma membrane-enriched fraction 
derived from rat aortic myocytes in culture, 8 days after 
plating. M, markers: phosphorylase b, bovine serum 
albumin, ovalbumin, carbonic anhydrase, soybean 
trypsin inhibitor and lysosyme (Mr 92500,66200,45000, 
31000, 21500 and 14400, respectively). 
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tion of CAMP and exogenous protein kinase 
revealed substrate proteins indicated by arrows in 
fig.1 (16, 24 and 35 kDa). In other experiments 
(not shown), the same pattern of labelled proteins 
was obtained with plasma membrane-enriched 
fractions isolated from myocytes in suspension. In 
all cases, phosphorylation of the 16 kDa protein 
was the most prominent and was therefore studied 
in more detail. 
Table 1 shows CAMP-dependent phosphoryla- 
tion of the 16 kDa protein in cytosolic and 
microsomal fractions obtained from 3 different 
Table 1 
16 kDa protein phosphorylation i  microsomal and 
cytosolic fractions from myocytes in culture, myocytes 
in suspension and from rat aorta media layer (pmol 
PO:-/mg protein) 
Microsomal Cytosolic 
fraction fraction 
(A) Myocytes in culture 34.2 + 0.9 n.d. 
(B) Myocytes in suspension 32.6 k 3.2 n.d. 
iC) Media layer 7.5 f 0.1 21.6 ?I 2.1 
20-25 pg protein was used in each assay. Results are 
given as mean SE f mean (n = 3); n.d., not detectable 
preparations: myocytes in culture (A), in suspen- 
sion (B) and from the media layer (C). In 
microsomal fractions, the intensity of 16 kDa pro- 
tein labelling was similar in A and B but lower in 
C. In cytosolic fractions, 16 kDa protein labelling 
was obvious in C but could not be detected in A 
and B. This indicates that homogenization of the 
media, a traumatic procedure, induces a loss of 
membrane 16 kDa protein content, whereas gentle 
homogenization of the myocytes does not. 
16 kDa protein phosphorylation was examined 
as a function of the plasma membrane enrichment 
of the fractions (table 2). The results show that the 
16 kDa protein co-enriched with the plasma mem- 
brane marker (Na+ + K+)-ATPase (invariant ratio 
a) but did not co-enrich with the endoplasmic 
reticulum marker NADPH-cytochrome c reduc- 
tase (variable ratio b). There is therefore strong 
evidence for plasma membrane localization of the 
16 kDa protein. 
The influence of the phosphatase inhibitor NaF 
[25] on 16 kDa protein phosphorylation is de- 
scribed in fig.2. An excess of non-radioactive ATP 
(lo-’ M final concentration) was added to max- 
imally phosphorylated 16 kDa protein [26]. Under 
these conditions, the decrease of 32P content of the 
protein during subsequeht incubation was a 
Table 2 
Distribution of (Na+ + K+)-ATPase activity [ 191, NADPH- 
cytochrome c reductase activity [20] and phosphate incorporation 
into 16 kDa protein in Fl, F2, F3 and F4 fractions [15] derived 
from the same myocyte culture, 8 days after plating (one 
representative xperiment out of 7) 
Membrane 
fractions 
(Na+ + K+)- 
ATPase 
Spec. act. a 
16 kDa NADPH-cyto- 
protein chrome c reductase 
labelling 
Spec. act. b 
Fl 108 1.9 56 3.6 0.06 
F2 70 2.7 25.8 3.7 0.14 
F3 42 2.6 16.2 4.7 0.29 
F4 n.d. - n.d. 6.2 - 
Units: (Na+ + K+)-ATPase, nmol P,/mg per min; NADPH- 
cytochrome c reductase, pmol/mg per min; 16 kDa protein 
labelling, pmol/mg protein. u and b are the ratio of enzyme 
activity/l6 kDa protein labelling for (Na+ + K+)-ATPase and 
NADPH-cytochrome c reductase, respectively; n.d., not 
detectable 
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z. Representative experiment of 16 kDa protein 
dephosphorylation in the absence or presence of 10 mM 
NaF (n = 3) [26]. Plasma membrane-enriched fractions 
were phosphorylated as described in section 2. After 
5 min incubation, lo-’ M non-labelled ATP was added 
and the decrease with time in PO:- content of the 
16 kDa protein was examined. 
measure of phosphatase activity. In the absence of 
NaF, 16 kDa protein phosphorylation declined to 
control levels after 15 min incubation, but in the 
presence of NaF, phosphorylation was stable. In 
. . 
‘. . 
-. . -No! 
addition, 16 kDa protein phosphorylation was 
I 10 IS TIFF (“\,“) resistant to hydroxylamine treatment (92% 
radioactivity retained by the protein after 15 min 
December 1985 
Table 3 
Influence of fl-adrenergic stimulation of aortic myocytes in culture on phosphorylation of 
the 16 kDa protein 
Drug 
Pre-treatment NaF n 16 kDa protein 
(25 mM) 
Time “PO:- labelling In situ 
(min) (pmollmg) phosphorylation’ 
(pmoljmg) 
Control 3 + 6 53.4 * 0.9 _ 
Iso (lo-’ M) 0.5 + 3 44.5 t- 0.8d 8.7 + 0.5 
3 + 6 31.0 f l.od 22.4 t 1.1 
3 _a 3 32.7 k 0.65d 20.8 + 0.6 
3 _b 3 47.4 * 1.3d 6.3 k 1.4 
Pro (5 x lo-’ M) 3 + 3 53.2 + 0.4 
N.S. - 
Iso (lo-’ M) 
Pro (5 x lo-’ M) 
3 + 3 49.8 * 0.8d 3.2 + 0.31 
a No preincubation 
b 15 min preincubation at 30°C 
’ Induced by pretreatment 
d p < 0.01, N.S., non-significant 
Labelling of the protein was performed in acellular medium by measuring the 
incorporation of PO:- after addition of labelled ATP, in the presence or absence of 
25 mM NaF (to inhibit phosphatase activity). In situ phosphorylation induced by 
pretreatment was calculated in each experiment by subtracting 16 kDa labelling found on 
the membrane fraction obtained from pretreated cells from 16 kDa labelling in the 
membrane fraction obtained from control cells. Results are given as mean + SE and were 
submitted to variance analysis. In each experiment control and pretreated cells came from 
the same pool of myocytes 
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in the presence of 0,8 M NH20H at 30°C), as ex- 
pected for a phosphoester linkage. The 16 kDa 
protein did not appear to be phospholamban-like 
because of its insensitivity to boiling (not shown). 
Since Iso produces CAMP accumulation in rat 
aortic myocytes, it presumably induces activation 
of intracellular CAMP-dependent protein kinase 
and a subsequent increase in phosphate incorpora- 
tion into target proteins. In vitro phosphorylation 
of these proteins should therefore be attenuated in 
membranes isolated from myocytes pretreated 
with Iso, provided that phosphoprotein phos- 
phatase activity is inhibited during the isolation 
procedure. As shown in table 3, phosphorylation 
of the 16 kDa protein was reduced by 17 and 45% 
in membrane fractions obtained from aortic 
myocytes stimulated by 10m7 M Iso for 30 s and 
3 min, respectively, 25 mM NaF being added to 
homogenisation and assay buffers. When NaF was 
omitted, the influence of Iso pretreatment disap- 
peared with time: in vitro phosphorylation of the 
16 kDa protein was attenuated by 38% when the 
assay was performed immediately after ho- 
mogenization but only by 11% when the mem- 
brane fraction was incubated for 15 min at 30°C 
prior to assay. Thus the influence of Iso pretreat- 
ment of the cells decreased markedly under the in- 
fluence of phosphoprotein phosphatase. In addi- 
tion the effect of Iso pretreatment was inhibited by 
Pro which alone had no effect. Altogether these 
results show that ,d-adrenergic stimulation of the 
cells attenuated subsequent in vitro CAMP- 
dependent phosphorylation of the 16 kDa protein 
and that this phenomenon disappeared if mem- 
brane protein phosphatase was not inhibited. 
4. DISCUSSION 
Rapoport et al. [6] have recently studied 
phosphorylation of microsomal and soluble pro- 
teins in aorta stimulated with drugs which increase 
intracellular CAMP. They detected phosphoryla- 
tion of cytosolic proteins only (21-49 kDa). Other 
studies have also concluded that CAMP did not in- 
crease smooth muscle microsomal phosphoryla- 
tion [ 1 l- 131, However, CAMP-dependent phos- 
phorylation of microsomal proteins (42 and 
44 kDa) have been reported in rat aorta [10,141. 
Three possible experimental differences may ac- 
count for these different results and may also ex- 
plain why phosphorylation of a 16 kDa membrane 
protein has not been previously detected. Firstly, 
homogenization of whole arterial tissue may in- 
duce membrane damage and, as shown here, loss 
of the 16 kDa protein which is not produced by 
gentle homogenization of cultured or isolated 
myocytes. Secondly, whole rat aorta as used in 
previous studies contains up to 50% of non- 
smooth muscle cells [27], whereas this study was 
performed on subcellular fractions of myocytes 
only. Lastly, phosphorylation experiments re- 
ported here were performed in an acellular 
medium, using a plasma membrane-enriched frac- 
tion. These conditions are much more sensitive for 
the detection of membrane substrates for protein 
kinase [28,29] than the incorporation of labelled 
phosphate into intact cells as used by Rapoport et 
al. [6]. 
Our results also provide strong evidence that P- 
adrenergic stimulation of aortic myocytes could in- 
duce in situ phosphorylation of a 16 kDa plasma 
membrane protein. Not only did Iso pretreatment 
of the myocytes decrease subsequent incorporation 
of labelled phosphate into the protein, but this ef- 
fect could also be abolished by endogenous 
phosphatase activity. In addition, membranes 
from &o-treated myocytes which had been 
dephosphorylated by endogenous phosphatase 
could then incorporate as much labelled phosphate 
as could control membranes from untreated 
myocytes. 
The concentration of Iso used was close to the 
concentration producing half-maximal relaxation 
and half-maximal accumulation of CAMP in 
isolated rat aorta with a peak effect reached after 
3 min [30]. At this concentration the effect of Iso 
on in situ phosphorylation of the 16 kDa protein 
could be detected after 30 s incubation, and after 
3 min it reached 45% of the in vitro maximal 
CAMP-dependent phosphorylation of the protein. 
As expected, this effect was strongly depressed by 
5 x lo-’ M Pro, These findings support the view 
that CAMP-dependent phosphorylation of a 
16 kDa protein may play a role in the effect of P- 
adrenergic stimulation in aortic myocytes. While 
this role is still unknown, it might bear on plasma 
membrane function(s) since the 16 kDa protein 
copurified with a plasma membrane marker. 
Other proteins of similar apparent molecular 
mass have recently been found in heart and liver 
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plasma membranes. The heart protein (15 kDa) is 
phosphorylated following Iso stimulation, is dif- 
ferent from phospholamban and is also a substrate 
for protein kinase C [28]. The liver protein 
(16 kDa) is phosphorylated by diacylglycerol- 
activated protein kinase C [31]. The role of these 
proteins is still unknown. However, it appears that 
the plasma membrane of several tissues, including 
rat aortic myocytes, contains low molecular mass 
proteins which are substrates for functionally im- 
portant protein kinases and may play a part in hor- 
monal regulation of cell functions. 
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